Hideki Kimura
Department of Clinical and Laboratory Medicine
Faculty of Medicine
Fukui Medical University
Yoshida
Japan
Name/email consistency: high
- Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels. Kimura, H., Miyazaki, R., Imura, T., Masunaga, S., Suzuki, S., Gejyo, F., Yoshida, H. Kidney Int. (2003)
- Cholesteryl ester transfer protein as a protective factor against vascular disease in hemodialysis patients. Kimura, H., Miyazaki, R., Suzuki, S., Gejyo, F., Yoshida, H. Am. J. Kidney Dis. (2001)
- The C677T methylenetetrahydrofolate reductase gene mutation in hemodialysis patients. Kimura, H., Gejyo, F., Suzuki, S., Miyazaki, R. J. Am. Soc. Nephrol. (2000)
- A cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients. Kimura, H., Gejyo, F., Yamaguchi, T., Suzuki, S., Imura, T., Miyazaki, R., Arakawa, M. J. Am. Soc. Nephrol. (1999)
- Lipid-binding proteins in rat and human kidney. Kimura, H., Fujii, H., Suzuki, S., Ono, T., Arakawa, M., Gejyo, F. Kidney Int. Suppl. (1999)
- A common mutation of cholesteryl ester transfer protein gene in dialysis patients. Kimura, H., Gejyo, F., Suzuki, S., Yamaguchi, T., Imura, T., Miyazaki, R., Ei, K., Ei, I., Oda, M., Miyakawa, Y., Arakawa, M. Kidney Int. Suppl. (1999)
- Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Kimura, H., Suzuki, Y., Gejyo, F., Karasawa, R., Miyazaki, R., Suzuki, S., Arakawa, M. Am. J. Kidney Dis. (1998)
- Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kimura, H., Gejyo, F., Suzuki, Y., Suzuki, S., Miyazaki, R., Arakawa, M. Kidney Int. (1998)
